Skip to main content
. Author manuscript; available in PMC: 2022 Aug 18.
Published in final edited form as: Ocul Immunol Inflamm. 2019 Dec 10;29(6):1064–1071. doi: 10.1080/09273948.2019.1687733

Figure 1.

Figure 1.

Estimates of gain and loss of 10 letters

Comparison of Kaplan-Meier curves for 10 letters of gain or loss, in the observational Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort and in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Cohort. The shading at the top and bottom (light gray for SITE, dark gray for MUST) indicate the percent of remaining patients who are 10 letters below or above, respectively, their baseline visual acuity.